Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Disclosure of Holdings

5 Nov 2008 16:51

For immediate release: 5 November 2008

Creon Corporation Plc ("the Company") DISCLOSURE OF HOLDINGS

Creon Corporation plc (AIM: CRO) has today received notification from Newton Nominess Ltd ("Newton") that Newton has increased its holding of ordinary shares of ‚£0.01 each in the Company ("Ordinary Shares") by 46,400 Ordinary Shares, such that Newton now holds 2,417,510 Ordinary Shares, representing approximately 15.07 percent. of the issued share capital of the Company.

In addition, the Company has also today been notified by Forestdale Trading limited ("Forestdale") that Forestdale holds 1,019,226 Ordinary Shares, representing approximately 6.35 percent. of the issued share capital of the Company.

- Ends -

For further information please contact:

Creon Corporation Plc Jonathan Freeman +44 (0)20 7752 0215

Daniel Stewart & Company Plc Oliver Rigby +44 (0)207 776 6550

GTH Media Relations Toby Hall +44 (0)20 7153 8039

Christian Pickel +44 (0)20 7153 8036

vendor

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.